Digital healthcare is an evolving space, accelerated by the COVID-19 pandemic. Despite significant advances made before the pandemic, there are unmet needs to address and immense potential to fulfil.
Pharma and Healthtech companies are becoming more versed in the requirements to enter the digital space however, important barriers to success remain. In this opinion piece, we highlight key barriers that can negatively impact Pharma and Healthtech companies entering digital healthcare.
- Landscape knowledge and awareness
- Customer base
- Regulatory requirements
- Due diligence before collaborations
- Timing of product strategy
- Healthcare infrastructure, readiness and capabilities
Facebook
Twitter
LinkedIn
Email
WhatsApp
